Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LifeMD, Inc. Director's Dealing 2022

Feb 15, 2022

33298_dirs_2022-02-14_e5eedc3e-0d1a-4a14-bd9c-40e79b650b77.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2022-01-11

Reporting Person: Mironov Alexander (President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-01-11 Common Stock X 22000 $1.75 Acquired 24857 Direct